可穿戴设备有限公司美股招股说明书(2025-09-25版)

Prospectus Supplement(To Prospectus dated October 18, 2023) We have entered into a sales agreement, or the Sales Agreement, with A.G.P./Alliance Global Partners, or AGP or the SalesAgent, dated September 25, 2025, relating to the sale of our ordinary shares, no par value, or Ordinary Shares, offered by thisprospectus supplement and the accompanying prospectus. In accordance with the terms of the Sales Agreement, we may offer and sellour Ordinary Shares, having an aggregate offering price of up to $7,400,000, from time to time through or to AGP as sales agent orprincipal. Sales of our Ordinary Shares, if any, under this prospectus supplement may be made in sales deemed to be an “at the marketoffering” as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended, or the Securities Act. AGP is notrequired to sell any specific number or dollar amount of securities, but will act as a sales agent using commercially reasonable effortsconsistent with its normal trading and sales practices, on mutually agreed terms between AGP and us. There is no arrangement forfunds to be received in any escrow, trust or similar arrangement. AGP will be entitled to compensation at a commission rate of 3.0% of the gross sales price per share sold pursuant to theterms of the Sales Agreement. See “Plan of Distribution” beginning on page S-12 for additional information regarding thecompensation to be paid to AGP in connection with the sale of the Ordinary Shares on our behalf. AGP will be deemed to be an“underwriter” within the meaning of the Securities Act, and the compensation of AGP will be deemed to be underwriting commissionsor discounts. We also have agreed to provide indemnification and contribution to AGP with respect to certain liabilities, includingliabilities under the Securities Act or the Securities Exchange Act of 1934, as amended, or the Exchange Act. Our Ordinary Shares are listed on the Nasdaq Capital Market, or Nasdaq, under the symbol “WLDS”. Warrants to purchaseOrdinary Shares issued as part of our initial public offering, or the IPO Warrants, are listed on Nasdaq under the symbol “WLDSW”.On September 24, 2025, the last reported sale price of our Ordinary Shares and IPO Warrants on Nasdaq was $5.67 per share and$4.05 per IPO Warrant, respectively. The aggregate market value of our outstanding Ordinary Shares held by non-affiliates as of the date of this prospectussupplement was approximately $51,953,489 based on 5,646,263 Ordinary Shares outstanding, 5,515,232 of which were held by non-affiliates, and a per share price of $9.42 based on the closing sale price of our Ordinary Shares on September 12, 2025. During theprior 12 calendar month period that ends on and includes the date of this prospectus supplement, we have offered $9.87 million ofsecurities pursuant to General Instruction I.B.5 of Form F-3. We are an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012, and have elected tocomply with certain reduced public company reporting requirements. Investing in the Ordinary Shares involves a high degree of risk. See the “Risk Factors” section beginning on page S-4of this prospectus supplement and page 3 of the accompanying prospectus, as well as our other filings that are incorporated byreference into this prospectus supplement and the accompanying prospectus. Neither the Securities and Exchange Commission, or the SEC, nor any state securities commission has approved ordisapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement or the accompanyingprospectus. Any representation to the contrary is a criminal offense. A.G.P. This prospectus supplement is dated September 25, 2025 TABLE OF CONTENTS PROSPECTUS SUPPLEMENT PAGES ABOUT THIS PROSPECTUS SUPPLEMENTS-iiCAUTIONARYNOTE REGARDING FORWARD-LOOKING STATEMENTSS-iiiPROSPECTUS SUPPLEMENT SUMMARYS-1THE OFFERINGS-3RISK FACTORSS-4USE OF PROCEEDSS-8DIVIDEND POLICYS-8CAPITALIZATIONS-9DILUTIONS-10PLAN OF DISTRIBUTIONS-12LEGAL MATTERSS-15EXPERTSS-15WHERE YOU CAN FIND MORE INFORMATIONS-15INCORPORATION OF CERTAIN INFORMATION BY REFERENCES-16 PROSPECTUS About this Prospectus1About Our Company2Risk Factors3Cautionary Note Regarding Forward-Looking Statements4Capitalization6Use of Proceeds6Description of Securities7Plan of Distribution14Expenses16Legal Matters16Experts16Enforceability of Civil Liabilities17Incorporation of Certain Information by Reference18Where You Can Find Additional Information19 ABOUT THIS PROSPECTUS SUPPLEMENT This prospectus supplement and the accompanying prospectus are part of a shelf registration statement that we filed with theU.S. Securities and Exchange Commission, or the SEC, utilizing a “shelf” registration process. Under this shelf registration process,we may sell the securities described in our base prospectus included in the shelf registration statement in one or more offerings up to atotal aggregate offering price of $30,000,000. A